PSTI mention in 4 wellness stocks to watch see below

patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Reply New Message

Prev Message Back To Forum Threaded View Next Message

emma

Rank: Treasurer [?]

Points: 16214 [?]

Votes: 82 Score: 2.3 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

PSTI mention in 4 wellness stocks to watch see below

posted on Apr 14, 2013 10:00PM

Pluristem Therapeutics (NASDAQ: PSTI): Current price $3.09

Pluristem has reported that subsequent to favorable preclinical studies, United Therapeutics Corporation received the green light to perform a human Phase I evaluation in Australia using Pluristem’s PLacental eXpanded cells in patients diagnosed with Pulmonary Arterial Hypertension. On June 20, 2011 United Therapeutics and Pluristem entered into a licensing agreement through which United Therapeutics will develop, market and sell Pluristem’s PLX-PAD cells for PAH.

1 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply